EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $6.5B | +6.7% |
| Gross profit | $5.1B | +7.4% |
| Operating income | $1.4B | +7.1% |
| Net income | $1.0B | +5.4% |
| EPS | $1.74 | +7.1% |
| Free cash flow | $1.4B | +15.6% |